Molecular link between insulin resistance, inflammation identified
August 27th, 2009 - 1:54 pm ICT by ANIWashington, Aug 27 (ANI): Scientists from Children’s Hospital of Pittsburgh have identified a molecular link between insulin resistance and inflammation.
According to senior author Dr H. Henry Dong, assistant professor, Department of Pediatrics, University of Pittsburgh School of Medicine, signs of low-grade systemic inflammation are common among people who have the pre-diabetic condition known as metabolic syndrome, as well as in animal models of obesity and type 2, or insulin-resistant, diabetes.
“But it’s not yet clear if there is a cause-and-effect relationship between chronic exposure to low-grade inflammation and the onset of insulin resistance,” he said.
“Other studies have shown that in patients who have inflammation and diabetes, insulin-sensitizing drugs seem to reduce inflammation while anti-inflammatory therapies improve sensitivity to insulin,” the expert added.
During the study, researchers examined the role played by a protein called Forkhead Box 01 (Fox01), which his previous research showed contributes to elevations in triglycerides in an animal model of obesity and diabetes.
They found in cultured cells and mouse experiments that Fox01 stimulates inflammatory white blood cells called macrophages, which migrate to the liver and adipose, or fat, tissue in insulin-resistant states, to increase production of a cytokine called interleukin-1 beta (IL-1B).
The cytokine in turn interferes with insulin signalling. Insulin typically inhibits Fox01, setting up a feedback loop in healthy tissues that helps regulate insulin levels.
“The findings suggest that when there is a lack of insulin or when cells such as macrophages are resistant to its presence, there are no brakes on Fox01’s stimulation of IL-1B and its further interference with insulin signaling,” said Dong.
“That might explain why chronic inflammation often is coupled with obesity and type 2 diabetes. Also, a drug that acts on Fox01 might be able to better control blood sugar,” he added.
The study appears in online version of Diabetes, one of the journals of the American Diabetes Association. (ANI)
- Macrophage protein plays major role in inflammation - Nov 03, 2010
- How fish oils work against diabetes - Sep 03, 2010
- Scientists illuminate cell pathway key to insulin resistance in type 2 diabetes - Feb 25, 2011
- Protein that modulates metabolic dysfunction in obesity identified - Jun 18, 2010
- Brain insulin plays critical role in development of diabetes - Feb 17, 2011
- New discovery may help reduce obesity complications - Feb 04, 2010
- Insulin reduces obesity-related inflammation - May 11, 2010
- Potential therapeutic target for curbing inflammation in fat people identified - Nov 04, 2009
- Neutralizing cytokine GM-CSF can halt multiple sclerosis - Apr 25, 2011
- Changes in fat cells linked to diabetes - Jul 07, 2010
- Human enzyme holds promise of weight loss - Nov 15, 2011
- Micro-RNA that regulates insulin in obesity identified - Apr 01, 2011
- Gene that regulates obesity and diabetes identified - Dec 15, 2009
- Cellular mechanism behind chronic inflammation, type 2 diabetes identified - Dec 22, 2010
- Obesity can cause resistance against insulin for diabetic patients: Study - Aug 16, 2010
Tags: animal model, animal models, cause and effect relationship, chronic exposure, chronic inflammation, cultured cells, diabetes insulin, diabetic condition, insulin levels, insulin resistance, insulin resistant diabetes, interleukin 1, metabolic syndrome, pediatrics university, pittsburgh school, s hospital, systemic inflammation, type 2 diabetes, university of pittsburgh school of medicine, white blood cells